Ghemaxan

Ghemaxan is an anticoagulant medication containing Enoxaparin Sodium, used for preventing and treating blood clots. It is suitable for haemodialysis, intraarterial, and intravenous use.

Ghemaxan is primarily used to prevent and treat blood clots in various medical conditions. It is often administered during haemodialysis to maintain the patency of the dialysis circuit. Additionally, it can be used intraarterially or intravenously to manage clotting risks during certain procedures.

Ghemaxan works by inhibiting the formation of blood clots, which helps maintain blood flow in medical devices like dialysis machines. Common effects may include bruising or bleeding at the injection site, as well as potential allergic reactions.

Ghemaxan should be handled with care to avoid accidental bleeding. It is important to follow medical guidance regarding its use, especially in patients with a history of bleeding disorders or those taking other anticoagulants. Proper storage and administration techniques are crucial.

Ghemaxan may interact with other medications that affect blood clotting, such as aspirin or warfarin. Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always consult a healthcare provider before combining Ghemaxan with other treatments.